Allergy

Blepharitis

COVID-19

Cataract

Comanagement

Comprehensive Eye Exams

Conjunctivitis

Contact Lenses

Cornea

Diabetic Eye Disease

Dry Eye

Geographic Atrophy

Glasses

Glaucoma

LASIK

Lens Technology

Lid and Lash

Myopia

Nutrition

Ocular Surface Disease

Optic Relief

Patient Care

Pediatrics

Presbyopia

Ptosis

Refractive Surgery

Retina

Technology

Therapeutic Cataract & Refractive

News

All News

Practice Management

Media

All Videos

Expert Interviews

Podcasts

Medical World News

Viewpoints

Insights

Case Based Roundtable Series

Case Studies

Case of the Quarter

Practice Ownership

Rapid Readout

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Blog

Publications

Digital Edition

Supplements And Featured Publications

iTech

Partners

Resources

Job Board

Subscribe

Articles

Does alcohol affect macular degeneration?

This expansion marks the first FDA clearance for an amblyopia treatment for this age range in more than 2 decades. 

FDA clears expansion of Luminopia amblyopia treatment to include 8 to 12 year old patients

Videos

At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.

ASCRS 2025: Enhancing patient outcomes with presbyopia-correcting IOLs

Of participants surveyed, 36% reported a fear of cataract surgery, with more than half of those specifically feared it would lead to vision loss. 

University of Cincinnati researchers find fear of vision loss may be deterring patients from cataract surgery

The leading source of breaking news, news analysis, and emerging research reports in optometry, Optometry Times® disseminates practical content by optometrists for optometrists that can be immediately applied to improve the clinical experience.

Advertise

About Us

Editorial

Contact Us

Terms & Conditions

Privacy

Do not sell my Information

Optometry Times | Clinical News & Expert Optometrist Insights

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Myopia- Management

1rem

Authors

Alex Christoff is assistant professor of ophthalmology at The Wilmer Eye Institute at Johns Hopkins Hospital in Baltimore. E-mail him at achris15@jhmi.edu.

The common eye problems found in adults, developing over decades of life as acquired disease, are different in children. There is an old pediatrics adage that “children are not little adults.” This is certainly true when it comes to the pediatric eye exam that many allied health care personnel find themselves facing, often with dread, on a weekly or daily basis.

Examining pediatric eyes

Griffey Eye Care, the leading cataract surgery center in the region, is proud to announce it will begin offering the RxSight Light Adjustable Lens® (LAL) to cataract patients this month. Griffey Eye Care is the first practice in Chesapeake to provide this cutting-edge technology, revolutionizing the way cataract surgery outcomes are personalized.

The RxSight Light Adjustable Lens is the only intraocular lens implant that allows ophthalmologists to adjust a patient’s vision after cataract surgery, providing unparalleled precision and customization.

“By offering the Light Adjustable Lens, we can now provide our patients with even more accurate and tailored vision outcomes than ever before,” said Dr. Paul Griffey, a leading laser cataract surgeon at Griffey Eye Care. “We are always looking for ways to enhance the care we provide, and the LAL is a game-changing tool in achieving that goal.”

Cataract surgery is the most common surgical procedure in the United States, with roughly 50% of Americans developing cataracts by the age of 75. This percentage is expected to grow as life expectancy increases. Cataracts occur when the natural lens of the eye becomes clouded, leading to blurred or diminished vision.

During cataract surgery, the eye's cloudy natural lens is removed and replaced with a synthetic intraocular lens (IOL). Until now, surgeons relied on pre-surgery measurements to estimate a patient’s post-operative vision correction. The RxSight Light Adjustable Lens changes the game by allowing for post-surgery adjustments, ensuring the most precise vision correction possible.

Studies show that patients who receive the LAL, along with the recommended post-surgery treatments, are more likely to achieve 20/20 vision or better without the need for glasses, compared to those with standard lens implants.

The LAL is made from a proprietary material that can be fine-tuned using the RxSight Light Delivery Device, which uses targeted ultraviolet light to adjust the lens to meet each patient’s specific vision needs.

“Because small variations in healing are common, the LAL allows us to fine-tune the lens for each patient’s unique eyes and lifestyle,” Griffey explained.

Griffey Eye Care has three convenient locations, two in Chesapeake and one in Virginia Beach. To schedule a cataract consultation, patients can call 1-888-873-9348.

Griffey Eye Care is a premier eye care center in Chesapeake and Virginia Beach, specializing in advanced cataract surgery, LASIK, and other vision correction procedures. Led by Dr. Paul Griffey, the practice is committed to providing the highest quality care using the latest technology and techniques to improve the vision and lives of its patients.

Griffey Eye Care and Laser Center introduces Light Adjustable Lens™ in Chesapeake

Chinese researchers found that repeated therapy using low-level red light (RLRL) is a potential intervention to control myopia progression in children; however, the investigators found decreases in cone density, particularly within 0.5 mm of the retinal fovea, with abnormal drusen-like lesions detected in some cases,

 reported Xinyi Liao, MD. She is from the Department of Ophthalmology, and the Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People’s Hospital; and the College of Optometry, Peking University Health Science Center, all in Beijing, China.

Liao and colleagues explained that RLRL therapy is being evaluated for its ability to inhibit myopia progression in children and adolescents.

 This therapy uses a wavelength of 650 ± 10 nm, with an optical power of at least 0.29 mW entering the 4-mm pupil, complying with the international safety standard for laser use.

 However, it has been reported that continuous irradiation may induce a photothermal effect and, therefore, cause retinal damage, despite adhering to international standards.

 The investigators cited a study of retinal damage associated with RLRL treatment that raised concerns about the potential harm to users.

The investigators used adaptive optics scanning laser ophthalmoscopy (AOSLO) in the current study because it enables high-resolution retinal imaging to measure cone cell density in vivo. In this study, they compared the changes in the cone photoreceptors in RLRL users with those in children with myopia aged 5 to 14 years who never underwent RLRL therapy.

 They obtained cone density measurements from the AOSLO images of the superior, inferior, nasal, and temporal meridians from the central fovea vicinity to approximately 4° retinal eccentricity to compare the differences in cone density and structure between cohorts, they described.

The study included 99 children with myopia. The RLRL group included 52 children (27 girls; 97 eyes; mean age, 10.3 years), and the control group included 47 children (25 boys; 74 eyes; mean age, 9.8 years).

“The RLRL users showed decreased cone density within 0.5-mm eccentricity from the foveal center, most notably in the temporal region. At 0.3-mm temporal eccentricity, the RLRL group showed a mean difference of −2.1 × 10

 compared with the controls (95% confidence interval [CI], −3.68 to −0.59 × 10

They also found that 11 eyes had abnormal low-frequency, high-brightness signals near the fovea. The odds ratio of abnormal signals in the patients who used RLRL compared with the controls was 7.23 (95% CI, 1.15-303.45; Fisher’s exact test, 

 = .02). One child had relatively small cystoid abnormalities in the ganglion cell layer seen on optical coherence tomography; these abnormalities resolved 3 months after the RLRL therapy was discontinued.

Liao and colleagues commented, “RLRL therapy administered for at least 1 year was associated with reduced cone density in the paracentral fovea and other subtle retinal abnormalities in some children receiving this therapy for myopia control compared with evaluation of nonusers of RLRL therapy. Although RLRL therapy might control the progression of myopia, further studies are needed to provide more definitive information regarding longer-term efficacy and safety. The AOSLO findings from this investigation support further evaluation of the risk-benefit balance of RLRL therapy in pediatric patients with myopia and potentially the inclusion of additional studies that include AOSLO evaluations as part of the efficacy and safety of RLRL therapy.”

Liao X, Yu J, Fan Y, et al. Cone density changes after repeated low-level red light treatment in children with myopia. 

 2025; Published online April 24. doi:10.1001/jamaophthalmol.2025.0835

Wang W, Jiang Y, Zhu Z, et al. Axial shortening in myopic children after repeated low-level red-light therapy: post hoc analysis of a randomized trial. 

He X, Wang J, Zhu Z, et al. Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial. 

Jiang Y, Zhu Z, Tan X, et al. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. 

Chen Y, Xiong R, Chen X, et al. Efficacy comparison of repeated low-level red light and low-dose atropine for myopia control: a randomized controlled trial. 

Youssef MA, Shehata AR, Adly AM, et al. Efficacy of repeated low-level red light (RLRL) therapy on myopia outcomes in children: a systematic review and meta-analysis. 

Zhou L, Tong L, Li Y, Williams BT, Qiu K. Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence. 

Xiong R, Zhu Z, Jiang Y, et al. Sustained and rebound effect of repeated low-level red-light therapy on myopia control: a 2-year post-trial follow-up study. 

LIA. American National Standard for Safe Use of Lasers home page. Accessed April 20, 2024. 

Ostrin LA, Schill AW. Red light instruments for myopia exceed safety limits.

Liu H, Yang Y, Guo J, Peng J, Zhao P. Retinal damage after repeated low-level red-light laser exposure.

Merino D, Loza-Alvarez P. Adaptive optics scanning laser ophthalmoscope imaging: technology update. 

Wynne N, Carroll J, Duncan JL. Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO). 

Researchers found that repeated therapy using low-level red light (RLRL) is a potential intervention to control myopia progression in children.

Changes in cone density after low-level red light treatment in children with myopia 

A new optical laboratory is now available for opticianry students at Seneca Polytechnic.

 The HOYA Vision Care Eyeglass Dispensing Lab at Seneca’s Newnham Campus provides an immerse learning experience for students to develop their skills through hands-on experiential learning in a space that replicates a high-end retail optical dispensing and vision testing environment, according to a news release.

“We are thankful to HOYA for the generous donation that made our new Dispensing Lab possible,” said David Agnew, president of Seneca Polytechnic, in the release. “Students are already benefitting tremendously from this new facility and its sophisticated equipment, ensuring that they transition seamlessly from education to employment.”

The laboratory is equipped with professional-grade technology, which allows students to practice skills including taking precise measurements, selecting appropriate frames, and ensuring proper fittings of eyewear. The space will be available for students in Seneca’s opticianry diploma program, which will authorize them to dispense contact lenses, eyeglasses, and subnormal vision devices.

“HOYA is proud to support the next generation of opticians through our sponsorship of Seneca Polytechnic and our commitment to the optical industry in Canada,” said Steven Haifawi, president of HOYA Vision Care, Canada, in the release. “We are ensuring that future eye care professionals have the skills, knowledge, and resources needed to provide great service to their communities.”

Seneca’s 2-year diploma program is offered in a hybrid delivery format, with some coursework that can be completed online and others to be completed in person. Students can choose from in-person, hybrid, and flexible formats. Courses are available in winter, summer, and fall semesters.

Students who graduate from the program have options for careers in retail optical dispensaries, contact lens clinics, medical clinics, and a health care delivery team. In Canada, registered opticians prepare work orders that give ophthalmic laboratory technicians information to prepare lenses for a frame. Some opticians prepare and finish lenses themselves. Opticians also work to verify the product is completed to the specifications ordered after the design is completed and the eyeglasses are made.

Some opticians in Canada specialize in fitting contact lenses, artificial eyes, or cosmetic shells to cover blemished eyes. Opticians will measure the eye, selecting contact lens material type, and preparing work orders. After delivery, opticians will assist with insertion and will inspect the patient’s eyes, corneas, lids, and contact lenses, and will provide insertion, removal, and care education to patients about their contacts, cosmetic shells, or artificial eyes.

Seneca Polytechnic launches new opticianry lab through gift from HOYA Vision Care. News release. Seneca Polytechnic. April 22, 2025. Accessed April 23, 2025. 

https://www.senecapolytechnic.ca/news-and-events/media-releases/2025/seneca-polytechnic-launches-new-opticianry-lab-through-gift-from-hoya-vision-care.html

Opticianry (OPTC). Seneca Polytechnic. Accessed April 23, 2025. 

https://www.senecapolytechnic.ca/programs/fulltime/OPTC.html

Scope of practice. NACOR. Accessed April 23, 2025. 

https://nacor.ca/about/opticians/scope-of-practice/

The laboratory is equipped with professional-grade technology and replicates a high-end retail optical dispensing and vision testing environment.

New HOYA Vision Care Eyeglass Dispensing Lab available for Seneca Polytechnic opticianry students

Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance. 

Arkansas Optometric Association outlines its latest legislature success in HB 1353

Starting in August 2025, with additional provisions to roll out based on plan renewals, contract changes, or by January 1, 2026, the relationship between optometrists and vision benefits managers (VBMs) will be changing in the state of Arkansas. HB 1353 will work to rebalance providers’ interactions with VBMs by expanding regulations and implementing more extensive reimbursement requirements. Joe Sugg, OD; Matt Jones, OD; and Matt Burns, OD; legislative cochairs with the Arkansas Optometric Association (ArOA), sat down with 

to discuss the new legislation. They emphasized how the association provides a unified platform for optometrists to address industry challenges collectively. 

The key motivations behind the bill stem from long-standing issues in vision care contracts. Optometrists have been facing increasingly restrictive "contracts of adhesion" with vision plans, where providers have minimal negotiation power. These contracts have consistently squeezed independent practitioners, particularly regarding reimbursement rates that have remained stagnant despite rising operational costs. Sugg and Jones, who have both been private practice owners since 2009, detailed how vision benefit managers have been vertically integrating the market by consolidating frames, labs, electronic health records, and e-commerce platforms. This consolidation creates significant pressure on small business owners and limits their competitive capabilities. 

The bill's development involved collaboration with the American Optometric Association (AOA) and leaders nationwide. Their goal was to create legislation that would protect eye care providers and improve patient access. The speakers noted similar legislative efforts in states like Texas and Oklahoma, expressing hope that the Arkansas bill might inspire nationwide reform. When presenting the bill to legislators, they found surprising receptivity. Lawmakers quickly understood the parallels with pharmacy benefit manager regulations and recognized the need to protect small businesses. The bill's core principles seemed inherently logical to legislators – advocating for provider rankings based on quality of care rather than product sales. Jones highlighted the bill's consumer-friendly nature, arguing it would steer patients toward practices based on medical care quality instead of product sales. He also pointed out the stark reality that service reimbursement rates haven't increased since vision plans' inception, despite exponential increases in operational costs. 

Nationally, Jones and Sugg expressed optimism about potential federal legislation like the DOC Access Act, which could address similar issues in vision and dental insurance markets. Jones, Sugg, and Burns ultimately portrayed the bill as a critical step in protecting optometric practices and ensuring fair, patient-centered health care delivery.

Bausch + Lomb has announced that its ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 103,169,500 units, or 625,026 pounds, of used contact lenses, eye care, and lens care materials in the US.

 That weight is the equivalent of approximately 600 concert grand pianos, according to a news release.

“These award-winning recycling programs continue to drive a positive environmental impact, offering eye care professionals, patients, and consumers a way to properly recycle used eye health materials,” said Amy Butler, vice president of global environment, health, safety, and sustainability at Bausch + Lomb, in the release.

Contact lenses, eye care, and lens care materials are often inefficiently processed in standard recycling facilities due to their small size and the type of plastic used to manufacture them. Thus, they are disposed of in landfills or end up in waterways. In the US, an estimated 6 to 10 metric tons of disposed contact lenses end up in wastewater each year.

“The ONE by ONE and Biotrue Eye Care Recycling programs allow my practice and patients to responsibly recycle eye health items—something that wasn’t possible until these programs became available," said Jennifer Tsai, OD, of LINE OF SIGHT in New York, in the release. "We’re proud to collect these materials and contribute to a cleaner environment and healthier planet.”

The ONE by ONE Recycling program has collected over 101 million used contact lenses, blister packs, and top foils since the program’s launch in November 2016. For the Biotrue Eye Care Recycling program, 1.3 million eye drop single-dose units, lens cases, lens solution caps, and all Biotrue-branded eye drop bottles have been collected since the program’s April 2021 launch. Additionally, for every 10 lb collected for the ONE by ONE program, a $10 donation is made to Optometry Giving Sight. Bausch + Lomb also has a similar contact lens recycling program in Canada called Every Contact Counts.

The company works to measure its environmental metrics with its FEWW initiative, or fuel, energy, water, and waste.

Eye care practice providers are able to become a TerraCycle public drop-off point by requesting to join the program on TerraCycle’s 

. The company’s administrators will review applications, and volunteer administrators will manage the drop-off points. The administrators will also choose the location, hours, and accepted waste streams. Participants in the program also receive TerraCycle Recycling Rewards for the trash sent in, which can be redeemed as a cash donation to a school, charity, or nonprofit of your choice. To manage a drop-off site, the location needs to be monitored to ensure proper usage, and when boxes are filled, materials then need to be sealed and sent out with prepaid labels. There are no direct costs associated with managing a drop-off location.

After a shipment is sent out and arrives at a material recovery facility, the shipment information, date, weight, and material are recorded. After inspecting and sorting the packages, various material types are sent to third-party partners to recycle all accepted waste. The recycled trash is then made into new products, including outdoor furniture, plastic pellets, tubing for construction applications, and playground surface covers, among others.

Bausch + Lomb reports more than 100 million units of contacts lenses, lens care, and eye care materials collected through ONE by ONE and Biotrue Eye Care Recycling programs. News release. Bausch + Lomb. April 21, 2025. Accessed April 22, 2025. 

https://www.bausch.com/newsroom/news/?id=255

Bausch + Lomb ONE by ONE free recycling program (drop-off). TerraCycle. Accessed April 22, 2025. 

https://www.terracycle.com/en-US/brigades/bauschrecyclesinoffice#@40.77027075200147:-95.93705549677736zoom:4

Find a TerraCycle drop-off point. TerraCycle. Accessed April 22, 2025. 

https://www.terracycle.com/en-US/about-terracycle/drop_off_locations#@40.77027075200147:-95.93705549677736zoom:4

The ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 103,169,500 units.

Bausch + Lomb recycles a total of over 625,000 pounds of contact lenses and eye care products

Representatives from The Vision Council visited the White House in Washington, DC, to meet with Robin Colwell, deputy assistant to the president and deputy director of the National Economic Council, to discuss vision care and challenges posed by current trade policies.

 A group of representatives from several vision care organizations and companies met to emphasize how tariffs are increasing the cost of eyewear and vision products, many of which are considered Class I medical devices and essential to children, older patients, veterans, and low-income patients, according to a news release.

“We appreciated the opportunity to meet with the White House and share how foundational vision is to Americans’ everyday lives,” said Ashley Mills, CEO of The Vision Council. “This conversation allowed us to highlight both the essential nature of vision care and the impact that rising tariffs are having on our industry and the consumers we serve.”

Other industry leaders present for the meeting were Scott Shapiro, executive director of Industry Relations and former CEO of Europa Eyewear; Brandon Butler, president and CEO of Artisan Lab Network and PAL; Jamie Rosin, owner of Rosin Optical; and Ken Bradley, president and CEO of Eschenbach Optik of America. Shapiro outlined how his US-based manufacturing facility has faced challenges with imported components. He also provided background on how restrictive “Made in USA” labeling regulations can limit a company’s ability to accurately represent domestically assembled products. Butler underscored challenges faced by optical labs in reshoring production, particularly the lack of production in US-made machinery, and the financial strain that tariffs are causing on raw materials. Rosin highlighted the downstream health impacts on patients, particularly children and older adults, when rising costs delay access to care. Bradley stated that increased costs affect publicly funded programs like Medicare, Medicaid, and Veterans Affairs, which raises taxpayer burdens while reducing patients served.

The Vision Council also “presented constructive policy ideas aimed at supporting the administration’s goals while easing the pressure on providers and patients,” according to the release. Some of those ideas included revisiting the “Made in USA” labeling standards for products assembled domestically with imported components, regulatory parity with other Class I medical devices in the case that an exemption process is opened, and broader incentives to support domestic manufacturing and supply chain development.

“Our members are committed to strengthening US manufacturing while ensuring that vision care remains affordable and accessible,” Mills added. “We look forward to continuing the conversation and identifying practical solutions together.”

Currently, plastic eyeglass frames, over-the-counter reading glasses, complete eyeglasses, safety glasses, and goggles imported from China are among the products that would be most affected by tariffs, subject to a combined tariff rate of approximately 64% if reciprocal tariffs are rolled out next month. Sunglasses imported from China will be taxed at 63.5%. Additionally, a variety of eyeglass cases, lens processing equipment, and other optical machinery originating from China could face combined duty rates between 80% and 90%.

The Vision Council advocates for the vision industry during White House meeting. News release. The Vision Council. April 22, 2025. Accessed April 22, 2025. 

https://thevisioncouncil.org/blog/vision-council-advocates-vision-industry-during-white-house-meeting

Joy J. Optimism persists among eye care providers despite looming tariffs. 

April 10, 2025. Accessed April 22, 2025. 

https://www.optometrytimes.com/view/optimism-persists-among-eye-care-providers-despite-looming-tariffs

Vision care organizations and companies met to emphasize how tariffs are increasing the cost of eyewear and vision products.

Alex Christoff, BS, CO, COT

Articles

Latest Updated Articles